(Q35172591)

6 August 2017

1 reference

title

Chronic widespread pain and fibromyalgia: what we know, and what we need to know (English)

1 reference

6 August 2017

0 references

chronic widespread pain

0 references

1

Daniel J Clauw

1 reference

6 August 2017

2

Leslie J Crofford

1 reference

6 August 2017

1 August 2003

1 reference

Best Practice & Research: Clinical Rheumatology

6 August 2017

1 reference

6 August 2017

17

1 reference

6 August 2017

685-701

1 reference

6 August 2017

4

1 reference

The prevalence and characteristics of fibromyalgia in the general population.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Population study of tender point counts and pain as evidence of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Risk factors for persistent chronic widespread pain: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Does chronic pain predict future psychological distress?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Factor analysis of unexplained severe fatigue and interrelated symptoms: overlap with criteria for chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Is there a Persian Gulf War syndrome? Evidence from a large population-based survey of veterans and nondeployed controls

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Chronic multisymptom illness affecting Air Force veterans of the Gulf War.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Psychologic distress and low back pain. Evidence from a prospective study in the general population.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Chronic widespread pain in the population: a seven year follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

An update on the epidemiology of knee and hip osteoarthritis with a view to prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Magnetic resonance imaging of the lumbar spine in people without back pain

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Comorbidity of fibromyalgia with medical and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The existence of a fatigue syndrome after glandular fever.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Symptom factor analysis, clinical findings, and functional status in a population-based case control study of Gulf War unexplained illness

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Health of UK servicemen who served in Persian Gulf War

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The Overlap Between Fibromyalgia and Inflammatory Rheumatic Disease: When and Why Does it Occur?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Possible deficiencies of pain modulation in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Why stress is bad for your brain

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Sympathetic nervous system function in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Multi-method assessment of experimental and clinical pain in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Modulation of pressure pain thresholds during and following isometric contraction

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Psychological and neural mechanisms of the affective dimension of pain

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Fibromyalgia and major affective disorder: a controlled phenomenology and family history study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Does the label "fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

If you have to prove you are ill, you can't get well. The object lesson of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Fibromyalgia, chronic fatigue, and other iatrogenic diagnostic algorithms. Do some labels escalate illness in vulnerable patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Classification, epidemiology, and natural history of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Treatment of fibromyalgia with antidepressants: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Treatment of fatigue in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Cognitive function in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Integration of Behavioral and Relaxation Approaches Into the Treatment of Chronic Pain and Insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Pain sensitivity, exercise and stoicism.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Complementary and alternative therapies for fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

The use of complementary medical therapies in the management of myofascial pain disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

Major life events and minor stressors: identifying mediational links in the stress process.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6942%2803%2900035-4

7 January 2021

10.1016/S1521-6942(03)00035-4

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12849719